EBIT: Income before interest and taxes.
Pasithea Therapeutics Corp. (KTTA) had EBIT of $-20.86M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-20.43M |
|
-- |
|
-- |
|
$20.86M |
|
$-20.86M |
|
$0.43M |
|
$-20.43M |
|
$-20.43M |
|
$-20.43M |
|
$-20.43M |
|
$-20.43M |
|
$-20.43M |
|
|
EBIT |
$-20.86M |
$-20.19M |
|
7.03M |
|
7.03M |
|
$-2.91 |
|
$-2.91 |
|
| Balance Sheet Financials | |
$56.46M |
|
-- |
|
$3.78M |
|
$60.24M |
|
$4.97M |
|
-- |
|
$0.05M |
|
$5.02M |
|
$55.22M |
|
$51.44M |
|
$55.22M |
|
23.09M |
|
| Cash Flow Statement Financials | |
$-15.21M |
|
$0.01M |
|
$63.52M |
|
$6.92M |
|
$55.26M |
|
$48.34M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-36.99% |
|
-39.71% |
|
-33.91% |
|
-36.99% |
|
$2.39 |
|
$-2.16 |
|
$-2.16 |
|